Emma Tinsley

Emma Tinsley is currently serving as the Chair of Remedy Rx since July 2021 and as the Chief Executive Officer of Weatherden since November 2017. Emma also holds the position of Advisor at Science Creates Ventures since June 2020. With previous experience as an Investment Associate and Finance and Operations Manager at SV Health Investors, Emma brings a wealth of knowledge in the finance and investment industry. Prior to that, Emma worked at KPMG as an Accounting and Advisory Services Assistant Manager and Assistant Manager (Life Sciences). Emma's educational background includes a MSci in Chemistry from the University of Bristol and an ACA in Accounting from ICAEW.